04 June, 2017
Its down 0.21, from 1.26 in 2016Q3. Price T Rowe Associates Inc /Md/ owns $492.79 million in Acadia Healthcare Company, Inc., which represents roughly 12.7% of the company's market cap and approximately 10.91% of the institutional ownership. 41 funds opened positions while 84 raised stakes.
05/31/2017 - Acadia Healthcare Company, Inc. had its " rating reiterated by analysts at KeyBanc. Mizuho restated a "buy" rating and issued a $52.00 price objective (up from $45.00) on shares of Acadia Healthcare Company in a report on Monday, February 27th.
Acadia Healthcare Company (NASDAQ:ACHC) last issued its quarterly earnings results on Tuesday, April 25th. 1,351 are held by Da Davidson And. The legal version of this article can be read at https://www.thestockobserver.com/2017/06/04/acadia-healthcare-company-inc-achc-shares-bought-by-us-bancorp-de-updated.html. Acadia Healthcare Company had a return on equity of 8.91% and a net margin of 0.22%. Company insiders own 17.20% of the company's stock. Investors may also be paying close concentration to some simple moving average indicators on shares of Carnival Corporation (CCL). Northern Trust Corp increased its stake in shares of Acadia Healthcare Company by 24.4% in the third quarter. 12,800 are held by First Quadrant Lp Ca. Deutsche Comml Bank Ag owns 282,268 shares. Etrade Capital Ltd Liability accumulated 0.01% or 3,266 shares. The Crestwood Capital Management Lp holds 192,500 shares with $14.31M value, up from 164,300 last quarter. A rating of less than 2 means buy, "hold" within the 3 range, "sell" within the 4 range, and "strong sell" within the 5 range. Jupiter Asset Management Ltd.'s holdings in Acadia Healthcare Company were worth $5,549,000 as of its most recent SEC filing. According to Thomson Reuters, sell-side analysts are predicting a consensus target price of $47.63 on company stock. Citigroup maintained Boeing Co (NYSE:BA) rating on Monday, September 19. It looks like analysts are feeling bearish about the stock with overall sell-side analysts calling it a Buy. The stock has "Buy" rating by RBC Capital Markets on Tuesday, May 30. The company was maintained on Wednesday, October 19 by RBC Capital Markets. The rating was initiated by Leerink Swann with "Outperform" on Tuesday, September 1.
Amid volatile financial markets and the presidential election, various investment brokerages have made amendments to their price targets and ratings on shares of Acadia Healthcare Company, Inc.
Stock analysts at Jefferies Group raised their Q2 2017 earnings estimates for shares of Acadia Healthcare Company in a research report issued to clients and investors on Thursday. During the same period in the prior year, the company posted $0.55 earnings per share. ACHC's profit would be $57.06 million giving it 16.82 P/E if the $0.65 EPS is correct.
TRADEMARK VIOLATION NOTICE: "Insider Selling: Acadia Healthcare Company Inc (ACHC) COO Sells 86,483 Shares of Stock" was originally reported by Transcript Daily and is owned by of Transcript Daily.
Since December 12, 2016, it had 0 insider purchases, and 9 insider sales for $130.86 million activity. Shares for $44,194 were sold by Schwieger Scott. About 1.53M shares traded. The shares were sold at an average price of $43.55, for a total transaction of $39,804.70. $44,194 worth of Acadia Healthcare Company Inc (NASDAQ:ACHC) shares were sold by Schwieger Scott. Sands Anita M sold 2,107 shares worth $192,095.
Acadia Healthcare Company, Inc is a provider of behavioral healthcare services, with operations in the United States and the United Kingdom. The company has market cap of $3.76 billion. The Company focuses on acquiring and developing behavioral healthcare facilities. It has a 290.34 P/E ratio. The Company operates through two segments: U.S. Facilities and U.K. Facilities. Four equities research analysts have rated the stock with a hold rating, seven have assigned a buy rating and one has issued a strong buy rating to the company's stock. Therefore 44% are positive. Acadia Healthcare had 26 analyst reports since August 6, 2015 according to SRatingsIntel. Also, COO Ronald Morgan Fincher sold 86,483 shares of the business's stock in a transaction on Monday, May 1st. Cantor Fitzgerald has "Neutral" rating and $4 target. The rating was initiated by Standpoint Research on Wednesday, August 26 with "Buy". The firm has "Buy" rating by Deutsche Bank given on Monday, December 5.
The company maintained ROI for the last twelve months at 6.70%. The Firm is engaged in the production and sale of short fiber pulp from its pulp production facilities located in the cities of Aracruz (State of Espirito Santo), Tres Lagoas (State of Mato Grosso do Sul), Jacarei (State of Sao Paulo) and Eunapolis (State of Bahia).
Investors sentiment decreased to 0.94 in 2016 Q4. Its down 0.04, from 0.99 in 2016Q3. It worsened, as 69 investors sold BA shares while 508 reduced holdings. 53 funds opened positions while 92 raised stakes. 32,351 are held by Wellington Mngmt Gru Llp. The Menora Mivtachim Holdings Ltd holds 242,600 shares with $37.77M value, down from 251,400 last quarter. Northpointe Limited Liability Co holds 0% or 206 shares. Jpmorgan Chase And Communications reported 7.65M shares. American Research And Mngmt Com accumulated 1,405 shares. Citadel Ltd has 0% invested in Fibria Celulose SA (ADR) (NYSE:FBR) for 33,082 shares. Salient Advsrs Ltd reported 0.01% of its portfolio in Boeing Co (NYSE:BA). Blackrock Invest Management Lc holds 39,710 shares or 0% of its portfolio.
